MicroPort Scientific Corporation (MCRPF) Stock Price & Analysis
MicroPort Scientific Corporation (MCRPF) — price $1.57 (0.00%), as of the Nov 18, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
MicroPort Scientific Corporation · MCRPF
MicroPort Scientific Corporation manufactures and distributes medical devices globally. The company operates through multiple segments, including cardiovascular, orthopedic, and surgical robotics.
Price as of Nov 18, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $1.57 |
| Change on the day | 0.00% |
| Price / earnings (trailing) | 31.22 |
| Shares traded on the day | 1.0K |
Price & events
Other perspectives
Council score for MicroPort Scientific (MCRPF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is MicroPort Scientific (MCRPF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. MicroPort Scientific Corporation (MCRPF) is the company analyzed here. It employs 6,547 people. In Q4 FY2025 it reported revenue of $448M and net income of $95M.
What do the latest results show for MicroPort Scientific (MCRPF)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of $448M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | $448M | $95M | $0.04 (diluted) |
| Q2 FY2025 | $548M | -$47M | -$0.03 (diluted) |
| Q4 FY2024 | $473M | -$117M | -$0.06 (diluted) |
| Q2 FY2024 | $559M | -$97M | -$0.05 (diluted) |
What are the financial strengths and risks for MicroPort Scientific (MCRPF)?
Short answer · as of
The distress and quality screens read Altman Z 0.13 · Piotroski F 6. Trailing ratios: ROE 6.1% · ROA 1.3% · current ratio 1.45 · earnings yield 3.8% · free-cash-flow yield -2.7%.
What should you watch next at MicroPort Scientific (MCRPF)?
Short answer · as of
Analyst estimates on file carry FY2026 revenue $1.18B · EPS 0.05 · 7 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $1.18B
- EPS estimate
- $0.05
Measured against a quoted price of $1.57 (as of Nov 18, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MCRPF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MCRPF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About MCRPF
These answers are editorial: 1 of these 8 answers is drawn from the MCRPF research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is MCRPF a good stock to buy?
Stock Expert AI does not rate MCRPF buy, sell or hold. MicroPort Scientific Corporation has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the MCRPF stock price today?
The last price recorded for MicroPort Scientific Corporation (MCRPF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What do analysts say about MCRPF stock?
Analyst coverage of MCRPF is limited due to its OTC listing. However, the company's growth potential in the medical device industry, particularly in surgical robotics and emerging markets, is generally viewed positively. Key valuation metrics, such as its negative P/E ratio, reflect its current lack of profitability.
What are the key factors to evaluate for MCRPF?
Evaluate MCRPF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Global presence in the People's Republic of China, North America, Europe, other Asian countries, and South America. Not financial advice.
How frequently does MCRPF data refresh on this page?
MCRPF's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven MCRPF's recent stock price performance?
MicroPort Scientific Corporation (MCRPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across multiple medical device segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MCRPF overvalued or undervalued right now?
The trailing P/E of MicroPort Scientific Corporation (MCRPF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MCRPF before investing?
Before investing in MicroPort Scientific Corporation (MCRPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 9 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com